High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

BACKGROUND: Malignant melanoma is the most lethal form of skin cancer with a variable clinical course even in patients with thin melanomas and localized disease. Despite increasing insights into melanoma biology, no prognostic biomarkers have yet been incorporated into clinical protocols. Reduced ex...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Nodin, Björn, Fridberg, Marie, Jonsson, Liv, Bergman, Julia, Uhlén, Mathias, Jirström, Karin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433373/
https://ncbi.nlm.nih.gov/pubmed/22805320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-7-82
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia